For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Ministry confirms death of a person in isolation
Ministry confirms death of a person in isolation

The Ministry is today sadly reporting a death of a person with COVID-19.
However the cause of death is unknown and may have been COVID-19 or some other cause. This will be determined by the Coroner.
The Ministry is working with other agencies, routinely involved in any sudden death, including Police and other health organisations.
The person had been isolating at a Manukau address.
The person was found deceased by a family member visiting them today. The person tested positive for COVID-19 on 24 October and has been isolating at home with public health oversight.
The Ministry extends its sympathies to this person’s family and acknowledges the stress this may cause them.